Bixiye
P13-20 Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers- eviCore Healthcare Utilization Management (UM) Program
Taariikhda uu dhaqangalayo Barnaamijka: 03, Feb 2020
Natiijooyinka Raadinta
Soo bandhiga 2521 - 2530 ee natiijooyinka 3698
Bixiye
P11-20 Updated Bulletin: Commercial Inpatient Admission Notification Process Changes
Taariikhda uu dhaqangalayo Barnaamijka: 03, Feb 2020
Bixiye
QP19-20 Provider Overpayments and Overpayment Recoupment for MHCP
Taariikhda uu dhaqangalayo Barnaamijka: 12, Feb 2020
Bixiye
QP22-20 Pharmacy Benefit Exclusion for Tepezza TM
Taariikhda uu dhaqangalayo Barnaamijka: 12, Feb 2020
Bixiye
QP16-20 Pharmacy Benefit Exclusion for Padcev TM and Enhertu ®
Taariikhda uu dhaqangalayo Barnaamijka: 12, Feb 2020
Bixiye
QP12-20 Reminder for Referring Subscribers to Participating Providers
Taariikhda uu dhaqangalayo Barnaamijka: Jan 22, 2020
Bixiye
QP1-20 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Palforzia and Viaskin Peanut (Peanut Allery Oral Immunotherapy)
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2020
Bixiye
QP4-20 Minnesota Health Care Programs (MHCP) and Minnesota Senior Health Options (MSHO) Behavioral Health Fax Back Notification Update
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2020
Bixiye
QP5-20 Pharmacy Benefit Exclusions
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2020
Bixiye
QP3-20 Addition of Mille Lacs Corporate Ventures to the American Indian Tribal Fee Schedule for Eligible Facility and Professional Services Provided to Purchased/Referred Care (PRC) – Eligible American Indians
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2020